Pharmaceutical market now ‘risky’

Geographical indicators to be developed for kava A leading kava scientist in the Pacific has labelled as "risky" any kava comeback in the pharmaceutical market, stressing that success of the crop as an export commodity

Read More

Fiji Kava signs China deal

Fiji Kava hopes to make inroads into the Chinese market with the signing of an exclusive distribution contract with Pumate Shanghai, which seeks to generate $8 million in revenue within its first three years. The

Read More